Solid Biosciences (SLDB) Receivables - Other (2020 - 2022)
Solid Biosciences (SLDB) reported Receivables - Other of $14000.0 for Q1 2022, down 95.0% on a YoY basis from $280000.0 in Q1 2021, and down 87.27% sequentially from $110000.0 in Q4 2021.
Solid Biosciences (SLDB) Receivables - Other (2020 - 2022) Analysis & Trends
Solid Biosciences (SLDB) has 3 years of Receivables - Other data on file, last reported at $14000.0 in Q1 2022.
- For the quarter ending Q1 2022, Receivables - Other fell 95.0% year-over-year to $14000.0; the trailing twelve-month figure through Mar 2022 stood at $14000.0 (down 95.0% YoY), and the FY2021 full-year result was $110000.0, changed N/A from the prior year.
- Receivables - Other eased to $14000.0 in Q1 2022, from $110000.0 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $594000.0 in Q3 2021 to a low of $14000.0 in Q1 2022.
- A 3-year average of $261666.7 and a median of $283000.0 in 2020 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other changed 0.0% in 2021 and tumbled 95.0% in 2022, its largest moves.
- Tracing SLDB's Receivables - Other over 3 years: stood at $286000.0 in 2020, then tumbled by 61.54% to $110000.0 in 2021, then slumped by 87.27% to $14000.0 in 2022.
- Business Quant data shows SLDB's Receivables - Other at $14000.0 in Q1 2022, $110000.0 in Q4 2021, and $594000.0 in Q3 2021.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Solid Biosciences | 529.40 Mn | 529.40 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2022 | 14,000.00 |
| Mar 31, 2022 | 14,000.00 |
| Dec 31, 2021 | 110,000.00 |
| Dec 31, 2021 | 110,000.00 |
| Sep 30, 2021 | 594,000.00 |
| Sep 30, 2021 | 594,000.00 |
| Jun 30, 2021 | 286,000.00 |
| Jun 30, 2021 | 286,000.00 |
| Mar 31, 2021 | 280,000.00 |
| Mar 31, 2021 | 280,000.00 |
| Jun 30, 2020 | 286,000.00 |
| Jun 30, 2020 | 286,000.00 |